Skip to main content

Read an important notice regarding the data security incident McKesson reported on August 28, 2026. Read more.

Clinical Trials

BRCC Research Institute 2026

< All Clinical Trials

A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

Disease Type: Breast

A Phase 1b/2, Open-Label, Multicohort Study of Disitamab Vedotin in Adults with HER2 Expressing Advanced Breast Cancer

Locations

Alleghany , Blacksburg , Roanoke , Salem , Wytheville

View on ClinicalTrials.gov